Veterinary Medicines

AviPro THYMOVAC Lyophilisate for use in drinking water

Authorised
  • Chicken anaemia virus, strain CUX-1, Live
Download as PDF

Product identification

Medicine name:
AviPro THYMOVAC Lyophilisate for use in drinking water
AviPro THYMOVAC lüofilisaat joogivees manustamiseks
Active substance:
  • Chicken anaemia virus, strain CUX-1, Live
Target species:
  • Chicken
Route of administration:
  • In drinking water use

Product details

Active substance and strength:
  • Chicken anaemia virus, strain CUX-1, Live
    31622.00
    50% tissue culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate for use in drinking water
Withdrawal period by route of administration:
  • In drinking water use
    • Chicken
      • Meat and offal
        no withdrawal period
      • Egg
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI01AD04
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Estonia
Package description:
  • (ID10): 1 Box with 10 Bottle (Glass) with 10000 Dose (100000 Dose)
  • (ID9): 1 Box with 1 Bottle (Glass) with 10000 Dose (10000 Dose)
  • (ID8): 1 Box with 10 Bottle (Glass) with 5000 Dose (50000 Dose)
  • (ID7): 1 Box with 1 Bottle (Glass) with 5000 Dose (5000 Dose)
  • (ID6): 1 Box with 10 Bottle (Glass) with 2500 Dose (25000 Dose)
  • (ID5): 1 Box with 1 Bottle (Glass) with 2500 Dose (2500 Dose)
  • (ID1): 1 Box with 1 Bottle (Glass) with 500 Dose (500 Dose)
  • (ID2): 1 Box with 10 Bottle (Glass) with 500 Dose (5000 Dose)
  • (ID4): 1 Box with 10 Bottle (Glass) with 1000 Dose (10000 Dose)
  • (ID3): 1 Box with 1 Bottle (Glass) with 1000 Dose (1000 Dose)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Lohmann Animal Health GmbH
Marketing authorisation date:
Manufacturing sites for batch release:
  • Lohmann Animal Health GmbH
Responsible authority:
  • State Agency Of Medicines
Authorisation number:
  • 1558
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0247/001
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Greece
  • Hungary
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Estonian (PDF)
Published on: 6/09/2024
Updated on: 19/09/2024
Download

Combined File of all Documents

English (PDF)
Published on: 5/11/2024
Download